Company / Operating Income
Disc Medicine, Inc. Operating Income History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$236.0M
FY2025
5-year range
-$236.0M / -$30.9M
FY2021-FY2025
Trend
-81.9%
vs FY2024
Sector context
#155 of 204
Health Care
What the data says
Disc Medicine, Inc.'s operating income of -$236M is lower than 76% of companies in the Health Care sector (FY2025). Operating Income has declined for 4 consecutive years, from -$31M in FY2021 to -$236M in FY2025.
Based on SEC 10-K filings.
-$236M in FY2025.
Declined from -$91M to -$236M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 204This company -$236.0M Sector average $107.8M
▼
-319.0% below sector average
Key checks
Key Insights
- Disc Medicine, Inc.'s operating income has declined for 4 consecutive years.
- In FY2025, operating income decreased 81.9% year-over-year.
- Ranks #155 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 4.41 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$236.0M | -81.9% |
| FY2024 | -$129.7M | -42.4% |
| FY2023 | -$91.1M | -91.9% |
| FY2022 | -$47.5M | -53.5% |
| FY2021 | -$30.9M | +9.1% |
| FY2020 | -$34.0M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026